Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 93 Records) |
| Query Trace: Neoplasms and IDH2[original query] |
|---|
| Analysis of ALK, IDH1, IDH2 and MMP8 somatic mutations in differentiated thyroid cancers. Molecular and clinical oncology 2021 8 15 (4): 210. Murugan Avaniyapuram Kannan, Qasem Ebtesam, Al-Hindi Hindi, Alzahrani Ali |
| Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma. Cells 2021 8 10 (8): . Murnyak Balazs, Huang L Er |
| Molecular Spectra and Frequency Patterns of Somatic Mutations in Arab Women with Breast Cancer. The oncologist 2021 Jul . Al-Shamsi Humaid O, Abu-Gheida Ibrahim, Abdulsamad Ahmed S, AlAwadhi Aydah, Alrawi Sadir, Musallam Khaled M, Arun Banu, Ibrahim Nuhad |
| Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 6 27 (16): 4491-4499. Mellinghoff Ingo K, Penas-Prado Marta, Peters Katherine B, Burris Howard A, Maher Elizabeth A, Janku Filip, Cote Gregory M, de la Fuente Macarena I, Clarke Jennifer L, Ellingson Benjamin M, Chun Saewon, Young Robert J, Liu Hua, Choe Sung, Lu Min, Le Kha, Hassan Islam, Steelman Lori, Pandya Shuchi S, Cloughesy Timothy F, Wen Patrick |
| Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes. Cancer 2021 Jun . Kanagal-Shamanna Rashmi, Montalban-Bravo Guillermo, Sasaki Koji, Darbaniyan Faezeh, Jabbour Elias, Bueso-Ramos Carlos, Wei Yue, Chien Kelly, Kadia Tapan, Ravandi Farhad, Borthakur Gautam, Soltysiak Kelly A, Routbort Mark, Patel Keyur, Pierce Sherry, Medeiros L Jeffrey, Kantarjian Hagop M, Garcia-Manero Guiller |
| Landscape of IDH1/2 mutations in Chinese patients with solid tumors: A pan-cancer analysis. Molecular genetics & genomic medicine 2021 Jun e1697. Shen Dong, Zhang Junling, Yuan Kai, Zhao Jing, Zhao Zhengyi, Cui Longgang, Zhang Yuzi, Wang Guoqiang, Cai Shangli, Bai Yuezong, Li Wei, Huang Xia |
| NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Molecular oncology 2021 May . Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Sánchez José M, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc |
| Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene. BMC cancer 2021 5 21 (1): 636. Heft Neal Molly E, Birkeland Andrew C, Bhangale Apurva D, Zhai Jingyi, Kulkarni Aditi, Foltin Susan K, Jewell Brittany M, Ludwig Megan L, Pinatti Lisa, Jiang Hui, McHugh Jonathan B, Marentette Lawence, McKean Erin L, Brenner J Ch |
| Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma. OncoTargets and therapy 2021 14 2953-2965. Wang Hao, Chen Shanhao, Meng Die, Wu Chunyan, Zhu Junjie, Jiang Minlin, Ning Jing, Wu Shengyu, Wu Lijia, Li Jingjie, Chen Bin, Zhao Sha, Li Wei, Yu Jia, Fang Qiyu, Zhu Jun, Zhao Wencheng, He Yayi, Zhou Caic |
| Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax. Blood advances 2021 Apr 5 (8): 2173-2183. Lachowiez Curtis A, Loghavi Sanam, Furudate Ken, Montalban-Bravo Guillermo, Maiti Abhishek, Kadia Tapan, Daver Naval, Borthakur Gautam, Pemmaraju Naveen, Sasaki Koji, Alvarado Yesid, Yilmaz Musa, Short Nicholas J, Chien Kelly, Ohanian Maro, Pierce Sherry, Patel Keyur P, Jabbour Elias, Ravandi Farhad, Kantarjian Hagop M, Garcia-Manero Guillermo, Takahashi Koichi, Konopleva Marina Y, DiNardo Courtney |
| Investigation of Isocitrate Dehydrogenase 1 and 2 Mutations in Acute Leukemia Patients in Saudi Arabia. Genes 2021 12 12 (12): . Alkhatabi Heba, Bin Saddeq Haneen Abdulfattah, Alyamani Luay, Shinawi Thoraia, Yasin Elrashed B, Alserihi Raed, Felimban Raed, Tayeb Hossam H, Mimani Rawan, Alalla Zainab, Abu-Elmagd Muhammad, Abuzenadah Ad |
| Evaluation of two new highly multiplexed PCR assays as an alternative to next-generation sequencing for IDH1/2 mutation detection. Molecular oncology 2022 9 16 (22): 3916-3926. Favre Loetitia, Sako Nouhoum, Tarfi Sihem, Quang Violaine Tran, Joy Corine, Dupuy Aurélie, Guillerm Erell, Gaulard Philippe, Wagner-Ballon Orianne, Pujals Anaïs, Sloma Iv |
| Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations. Cancer 2022 Sep . Ball Somedeb, Knepper Todd C, Deutsch Yehuda E, Samra Wassim, Watts Justin M, Bradley Terrence J, Chan Onyee, Hussaini Mohammad Omar, Zhang Ling, Sweet Kendra L, Kuykendall Andrew T, Talati Chetasi, Padron Eric, Komrokji Rami S, Lancet Jeffrey E, Sallman David |
| Periosteal chondrosarcoma: A case series in a referral center with survivorship analysis. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2022 6 48 (8): 1730-1738. Pacheco Marina, Barra Lucia, Gambarotti Marco, Magagnoli Giovanna, Sbaraglia Marta, Asioli Sofia, Cocchi Stefania, Carretta Elisa, Frisoni Tommaso, Benini Stefania, Dei Tos Angelo Paolo, Righi Alber |
| [Short-term efficacy of venetoclax combined with azacitidine in acute myeloid leukemia: a single-institution experience]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2022 4 43 (2): 134-140. Yu W J, Jia J S, Wang J, Tang F F, Gong L Z, Liu X H, Zhu X L, Zhao X S, Huang X J, Jiang |
| Next-Generation Sequencing in Lung Cancer Patients: A Comparative Approach in NSCLC and SCLC Mutational Landscapes. Journal of personalized medicine 2022 3 12 (3): . Pop-Bica Cecilia, Ciocan Cristina Alexandra, Braicu Cornelia, Harangu? Antonia, Simon Marioara, Nutu Andreea, Pop Laura Ancuta, Slaby Ondrej, Atanasov Atanas G, Pirlog Radu, Al Hajjar Nadim, Berindan-Neagoe Ioa |
| DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation. Frontiers in oncology 2022 3 12 849376. Jawad Majd, Afkhami Michelle, Ding Yi, Zhang Xiaohui, Li Peng, Young Kim, Xu Mina Luqing, Cui Wei, Zhao Yiqing, Halene Stephanie, Al-Kali Aref, Viswanatha David, Chen Dong, He Rong, Zheng Ga |
| Mutational characteristics of young and elderly gastric cancer: a comparative study. Journal of gastrointestinal oncology 2022 3 13 (1): 77-83. Li Long, Li Yin, Lin Li, Liu Yanling, Duan Linshan, Wang Dan, Cheng Shuyu, Liu Guoy |
| Analyzing the key gene expression and prognostics values for acute myeloid leukemia. Translational cancer research 2022 2 9 (11): 7284-7298. Shi Lingling, Huang Yan, Huang Xunjun, Zhou Weijie, Wei Jie, Deng Donghong, Lai Yongro |
| Dermatologic adverse events associated with IDH inhibitors ivosidenib and enasidenib for the treatment of acute myeloid leukemia. Leukemia research 2022 10 123 106970. Parisi Rose, Cowen Emily A, Stoll Joseph R, Zhu Haoling, Dusza Stephen, Pulitzer Melissa P, Stein Eytan M, Markova Ali |
| Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation Sequencing. Cancers 2022 1 14 (1): . Csoma Szilvia Lilla, Bedekovics Judit, Veres Gerg?, Árokszállási Anita, András Csilla, Méhes Gábor, Mokánszki Atti |
| Identification of prognostic and driver gene mutations in acute myeloid leukemia by a bioinformatics analysis. Translational cancer research 2023 7 12 (6): 1552-1564. Lifang Li, Jingxiong Ruan, Ning Zhang, Jia Dai, Xin Xu, Xudong Tian, Jian |
| Isocitrate Dehydrogenase 1 and 2 Mutations in Pediatric Neuroblastoma Patients. Medeniyet medical journal 2023 6 38 (2): 102-110. Emre Leventoglu, Gurses Sahin, Sule Yesil, Ceyhun Bozkurt, Nazmiye Yuksek, Ali Fettah, Sule Toprak, Burcak Kurucu Bilgin, Emre Capkinoglu, Nilgun Eroglu, Sibel Akpinar Tekgunduz, Ayse Ulya Ert |
| Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma. Cancer research communications 2023 3 3 (2): 192-201. Fanucci Kristina, Pilat Mary Jo, Shyr Derek, Shyr Yu, Boerner Scott, Li Jing, Durecki Diane, Drappatz Jan, Puduvalli Vinay, Lieberman Frank Scott, Gonzalez Javier, Giglio Pierre, Ivy S Percy, Bindra Ranjit S, Omuro Antonio, LoRusso Patric |
| Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors. JCO precision oncology 2023 3 7 e2200583. Aldea Mihaela, Tagliamento Marco, Bayle Arnaud, Vasseur Damien, Vergé Véronique, Marinello Arianna, Danlos François-Xavier, Blanc-Durand Felix, Bernard Elsa, Cerbone Luigi, Mosele Maria Fernanda, Renneville Aline, Hadoux Julien, Loriot Yohann, Sakkal Madona, Vozy Aurore, Sarkozy Clementine, Smolenschi Cristina, Nicotra Claudio, Martin-Romano Patricia, Boccon-Gibod Clementine, Habza Wafikaamira, Lazarovici Julien, Ponce Santiago, Hollebecque Antoine, Marzac Christophe, Lacroix Ludovic, Barlesi Fabrice, André Fabrice, Besse Benjamin, Rouleau Etienne, Italiano Antoine, Micol Jean-Baptis |
| Distinct IDH1/2-associated Methylation Profile and Enrichment of TP53 and TERT Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma. Cancer research communications 2023 3 3 (3): 431-443. Dermawan Josephine Kam Tai, Nafa Khedoujia, Mohanty Abhinita, Xu Yingjuan, Rijo Ivelise, Casanova Jacklyn, Villafania Liliana, Benhamida Jamal, Kelly Ciara M, Tap William D, Boland Patrick J, Fabbri Nicola, Healey John H, Ladanyi Marc, Lu Chao, Hameed Mee |
| The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia. Cancer medicine 2023 3 . Chen Xian, Tian Chuchu, Hao Zhuanghui, Pan Lingang, Hong Minglin, Wei Wei, Muyey Daniel Muteb, Wang Hongwei, Chen Xiuh |
| Oncogenic IDH1 Mutation Imparts Therapeutically Targetable Metabolic Dysfunction in Multiple Tumor Types. Cancer discovery 2023 2 13 (2): 266-268. Robinson Troy M, Levine Ross |
| The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour Microenvironment. Biologics : targets & therapy 2023 2 17 15-22. Kurdi Maher, Mulla Nasser, Katib Yousef, Alsinani Taghreed, Hakamy Sahar, Mj Addas Bassam, Malibary Husam, Halawa Taher F, S Farhan Marwa, Faizo Eyad, Baeesa Sal |
| Mutation analysis of the TERT gene in ovarian cancer patients of the Turkish population by next generation sequencing method. Cellular and molecular biology (Noisy-le-Grand, France) 2023 11 69 (11): 51-55. Betul Capar Gorali, Seda Gulec Y?lmaz, Fatma Tuba Akdeniz, Rukset Attar, Turgay ?sb |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: